Back to results
US 11,534,412 B2Granted
Application of totarol and pharmaceutical composition containing totarol
AssigneeEmergoPharm SP. z o.o. Sp.k.
InventorsMariusz Ciȩciara, Artur Wrzosek
Life of this patent
Estimating the term…
Loading patent…
Loading patent…
AssigneeEmergoPharm SP. z o.o. Sp.k.
InventorsMariusz Ciȩciara, Artur Wrzosek
Estimating the term…
The invention relates to application of totarol for production of a preparation for treatment of vaginal mucous membrane inflammations of bacterial origin, for alleviation of symptoms in such a treatment, and for prophylaxis and prevention of relapses of such inflammations. The invention includes also a pharmaceutical composition for treatment of vaginal mucous membrane inflammations of bacterial origin, for alleviation of symptoms in such a treatment and for prophylaxis and prevention of relapses of such inflammations, the composition containing from 75 to 95 parts by wt. of a cellulose derivative, from 0.5 to 5 parts by wt. of lactic acid, from 0.5 to 5 parts by wt. of a basic polymer, wherein the stoichiometric ratio of lactic acid to the basic polymer is comprised in the range of 1:1 to 8:1, and comprising totarol in an amount of 0.001 to 5 parts by wt. as the active substance.
A method for treatment of vaginal membrane inflammations of bacterial origin, for alleviation of symptoms in such a treatment, for prophylaxis and prevention of relapses of such inflammations, for treatment of anaerobic bacterial vaginosis (BV) and aerobic vaginitis (AV) comprising administering a pharmaceutical composition comprising totarol in an amount of 0.001 parts by weight (wt.) to 5.0 parts by wt. as an active agent.
A method for treatment of anaerobic bacterial vaginosis (BV) and aerobic vaginitis (AV), comprising:
The method according to claim d, wherein the basic polymer comprises at least one of the following:
Dependencies are inferred from the claim text.